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CORRECTION OF CLINICAL AND BIOCHEMICAL PARAMETERS USING BEE POLLEN IN 
PATIENTS WITH DIABETES 
Abstract. We have studied the effect of course taking bee pollen (BP) in patients with insulin-independent diabetes mel-
litus (IIDM). We have proven the efficacy and safety of BP in treatment of secondary manifestations of insulin-independent 
diabetes, a positive effect on some important links of pathogenesis of IIDM development (oxidant and antioxidant sys-
tems, lipid metabolism).
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резюме. Вивчено вплив курсового прийому пилку квіткового (ПК) у хворих на інсулін-незалежний цукровий діабет 
(ІНЦД). Доведена ефективність і безпечність ПК в лікуванні вторинних проявів інсулін-незалежного цукрового 
діабету, позитивний вплив на окремі важливі ланки патогенезу розвитку ІНЦД (оксидантну, антиоксидантну 
системи, ліпідний обмін). 
Ключові слова: цукровий діабет, пилок квітковий, оксидантна, антиоксидантна системи.
Introduction. Diabetes mellitus(DM) is a chronic endocrine-meta-
bolic disease caused by a relative deficiency of insulin due to the com-
bined effect of different endogenous (genetic) and exogenous factors 
that lead to the disorders in all types of metabolism, to a damage of 
vessels, nerves, different organs and tissues. A specific everpresent 
manifestation of the disease is a disorder in carbohydrate metabolism 
with progressive increase of blood glucose and its excretion with urine. 
The incidence is higher among the elderly. According to the fore-
cast of US experts in case of an increase in life expectancy to 80 years 
the number of diabetic patients in the USA will be more than 17% of the 
population. Ukraine’s population is also steadily aging. Gerontologists 
believe that in 25 years, almost every 3rd citizen of the country will 
be over 60 years old. Considering the socio-economic and ecological 
situation in Ukraine, the likelihood of unexpected growth of diabetes, 
especially of type 2, is very high. The highest incidence rate is observed 
among obese people. For instance, in moderately obese people the 
incidence of diabetes increased by 4 times, in those with sharply pro-
nounced obesity by 30 times. Thus, obesity and advanced age are 
among the main risk factors that cause a predisposition to diabetes [1, 
P.269-270; 2, p.111; 3, p.15-25].
The increase of morbidity, serious consequences of disability, es-
pecially among the working-age population contingent, high mortality 
made diabetes one of the three diseases that are the most common 
causes of morbidity and mortality among people (atherosclerosis, can-
cer, diabetes actually). The World Health Organization states that dia-
betes leads to increased mortality by 2-3 times and reduces life expec-
tancy by 10-30% [4, p.22-32]. 
Fighting diabetes is attributed to medical and social problems. This 
disease is a heavy burden for health care, with 80% of the costs for 
examination and treatment of diabetes accounts for patients with com-
plications. Therefore, many countries developed special national pro-
grams on diabetes. 
Bee pollen (BP), according to the research, as an antioxidant, li-
potropic agent, hepatoprotector, hastroprotector and immunomodulator 
can be used in primary and secondary prevention of secondary mani-
festations of diabetes [5, p. 10-15; 6, p. 8-12; 7, 191].
Objective: to study the effect of BP on clinical laboratory and organ 
functional and morphological manifestations of diabetes.
Materials and methods: The study involved 50 patients with in-
sulin-independent diabetes mellitus (IIDM) with concomitant chronic 
cholecystitis, among them - 40% of men and 60% of women aged 44 
to 76 years. Disease duration since diagnosing IIDM was from 4 to 
15 years. 20% of patients suffered from a mild form of the disease, 
the rest of them had moderately severe form (WHO classification of 
1985). Compensation of carbohydrate metabolism was found in 26% of 
patients subcompensation in 64%, decompensation in 10% of patients. 
All the patients, regardless of their age were diagnosed with coronary 
heart disease (CHD), of whom 60% of patients with exertional angina of 
functional class (FC) I (10%), FC II (28%), FC III (32%). The rest of the 
patients suffered from atherosclerosis of the aorta and coronary arter-
ies as well as from atherosclerotic cardiosclerosis. 
Results and discussion:
40% of patients had signs of fatty liver with minor, sometimes mod-
erately impaired liver function. In 58% of cases there were symptoms of 
visceral and peripheral neuropathies, particularly in the form of impaired 
gastric and intestinal motility and diabetic neuropathic gallbladder.
All patients were examined for a complex of biochemical parame-
ters (including blood glucose levels, blood cholesterol and triglycerides, 
liver function tests), blood count, immunogram, ionogram, the state of 
lipid peroxidation (LPO) and glutathione system, electrocardiography, 
ultrasound examination of the abdomen, in case of clinical manifesta-
tions of the cardiac lesion they underwent echocardiography.
The patients were administered a standard dietotherapy (1800 
kcal / day). Hypoglycemic therapy suggested maninil intake in doses 
corresponding to glycemia. In addition, the patients were treated with 
necessary pathogenetic therapy (nitropreparations, antirhythmic and 
anti-anxiety drugs). 
BP was administered to 30 patients against the background of ba-
sic therapy at a dose of 250 mg / kg of body weight twice a day in the 
form of an aqueous suspension in 100 ml of warm boiled water 20-30 
minutes before meals. The course of treatment lasted 21-28 days.
The control group consisted of 20 patients with IIDM suffering from 
coronary heart disease who were representative by age, gender and 
clinical features, fatty liver disease, visceral, and peripheral neuropathy. 
The patients in the control group only received the basic therapy. 
In order to avoid possible negative effect of BP like a significant 
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increase in blood glucose levels in diabetic patients, we studied the 
glycemia level in 20 patients two hours after taking a daily dose of pol-
len at one time before the beginning of the course of treatment. We 
found out that even a double dose of therapeutic BP does not cause 
a significant increase of glycemia compared with its level on an empty 
stomach. One hour after the intake of BP blood glucose rate grew by 
5.6% from the baseline, and after 2 hours it reduced to a level of only 
3.74% higher than the initial one. In the study of two-hour glycemia on 
an empty stomach we found: by the end of the first hour glucose rise by 
3.3% above the initial level with a decrease by the end of the second 
hour by 5% below the baseline. 
Against the background of a standard breakfast glycemic curve 
was qualitatively and quantitatively different. Therefore, the use of BP 
in diabetic patients is safe and does not require increasing doses of 
hypoglycohaemic drugs (Fig.). 
Fig. Effect of one time intake of double BP dose on the level glyce-
mia (duration of observation was 2 hours):
А - fasting glucose levels for 2 hours of observation;
В – glucose level after BP intake (at 8.00 am); 
С - blood glucose level during two hours after having a standard 
breakfast in IIDM patients in a state of a very good compensation
All the patients  felt less thirst in the course of taking BP (the amount 
of fluids decreased by 40% ) with a corresponding decrease in urine 
output. They had a feeling of satisfaction with meal and it eliminated 
the need for its frequent taking (and therefore helped reduce the vol-
ume and calorie content of daily meals). 80% of patients experienced 
a significantly decreased or disappeared feeling of heaviness in the 
right upper quadrant within two weeks. Patients with coronary artery 
disease felt a reduction in the frequency of attacks of heart pain and 
heart palpitations during exercise 5-6 days earlier than patients in the 
control group. We could observe the weakening effects of paresthesia 
and seizures in the muscles of the lower extremities, a pronounced 
shift of paresthesia upper border as early as on the second week of 
the course of treatment in 60% of patients, while patients in the control 
group needed vitamins and lipoic acid.to achieve this result. 
All the patients of the main group noted the improvement in health, 
efficiency and sense of vitality well before and more than patients in the 
control group. Patients who used BP even after the first year noted a 
significant decrease in the frequency of respiratory diseases, especially 
in autumn and winter, reducing the duration and severity in the event 
of their occurrence. Half of the patients could reduce the dose of hypo-
glycohaemic drugs  by ½-⅓  without worsening  glycaemia laboratory 
values  and clinical course of IIDM. 
According to one of the patients (diabetic doctor with long experi-
ence of the disease who was treated with pollen) when taking BP she 
felt healthier, more active, quality parameters of her life increased too.
However, in addition to the clinical results, there were positive 
changes in the findings of laboratory and instrumental studies. For in-
stance, the level of blood glucose after a course of BP declined on 
average by 22.3% compared with the figures before treatment, allow-
ing some patients to reduce the dose of maninil. The level of blood 
cholesterol in patients of the main group decreased significantly from 
5,77 ± 0,12 mmol / l to 4,94 ± 0,14mmol / L (p <0.05), while this value re-
mained virtually unchanged in the patients in the control group. In 50% 
of patients the blood triglycerides level decreased. All patients showed 
a clear tendency to increase blood and hemoglobin potassium levels 
while their previous rates were lowered.
Increased resistance of the body was confirmed by immunogram 
indicators: the number of T cells increased from 39.52 to 41.33, includ-
ing active ones from 20.61 to 22.31. The number of B-lymphocytes de-
creased from 32.40 to 28.31, the index of T-helper / T-suppressor - from 
2.06 to 1.86. The level of immunoglobulin G decreased on the average 
from 160,9h / l to 123.0 g / l. The circulating immune complexes were 
subjected to BP the most, their number decreased on the average from 
17,417.5 units to 13,010.4 units as well as the complement titer, which 
decreased from 0,056 to 0,038. 
Activation of peroxidation processes and reduction of antioxidant 
systems functional capacity in patients with IIDM were confirmed by 
our study. All the patients initially showed a significant increase in lipid 
peroxidation products (diene conjugates, isolated double bonds, ke-
todiens and conjugated triens) and decreased activity of glutathione 
system compared to those without diabetes. During the course of treat-
ment with a complex containing BP the level of isolated double bonds 
decreased from 5,38 ± 0,38 E220 / 1 mL of blood to 3,38 ± 0,30 E220 
/ 1 ml, diene conjugates from 2,97 ± 0, 31 E220 / 1 mL of blood to 2,31 
± 0,34 E220 / 1 mL of blood,  ketodiens and conjugated triens - from 
1,47 ± 0,145 E220 / 1 mL of blood to 0,87 ± 0,045 E220 / 1 mL of blood. 
The level of reduced glutathione in patients of the group increased by 
40% and the activity of glutathione reductase and glutathione-S-trans-
ferase decreased by 25.4% and 24.2% respectively. So, BP enhances 
the activity of antioxidant (glutathione system in particular) and causes 
inhibition of LPO, and consequently affecting one of the fundamental 
pathogenesis of IIDM secondary manifestations. 
Improving cardiovascular system in patients was confirmed by 
positive dynamics of ECG, which manifested itself by fewer signs of 
myocardial ischemia in ⅔ of patients.
Studying the gallbladder motility by means of dynamic echochol-
ecystography within one hour after administration of a double therapeu-
tic dose of BP showed that 85% of patients had a «diabetic neuropathic 
gallbladder» (atony, increased size, susceptibility to hypokinesia). BP 
cholekinetic effect, which was observed in patients without evidence of 
diabetes,was not found in the patients with this disease or was insignifi-
cant and short-lived. 
Repeated ultrasound of the gallbladder and liver after the first 
course of treatment did not show any significant changes in the ultra-
sound image, however, the patients who received two or three treat-
ments with bee pollen, showed a trend to improve the echostructure, 
to reduce its size, signs of fatty infiltration, reducing the gallbladder 
volume, wall thickening, its more active reaction to the introduction of 
choleretic drugs was noticed as well.
Since the start of using BP there have not been any allergic reac-
tions due to the intake of pollen in the patients with IIDM. There was 
one case, when the patient stopped taking pollen because of starting 
dyspepsia events (nausea, diarrhea), which she associated with the 
beginning of the BP use. Most of the patients generally tolerated the 
treatment very well and subsequently expressed a desire to continue 
receiving BP.
Conclusions.
1. Clinical testing of BP showed that it is a quite effective and safe natural remedy in the treatment and prevention of 
secondary manifestations of IIDM.
2. BP has a positive effect on some important links of pathogenesis of IIDM (oxidant and antioxidant systems, lipid 
metabolism, immune system) and improves the quality of life.
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DISORDERS OF RENAL FUNCTION IN IMMATURE RATS WITH INBLIMATE 
NEPHROPATHY AT LOADING BY 3% SODIUM CHLORIDE SOLUTION UNDER 
CONDITIONS OF RENAL PROSTAGLANDINS BLOCKADE WITH INDOMETHACIN
НАрУШеНИе ФУНКЦИИ ПОЧеК В НеПОЛОВОЗреЛыХ КрыС ПрИ СУЛеМОВОй 
НеФрОПАТИИ С НАГрУЗКОй 3% рАСТВОрОМ ХЛОрИДА НАТрИЯ В УСЛОВИЯХ 
БЛОКАДы ПОЧеЧНыХ ПрОСТАГЛАДИНОВ ИНДОМеТАЦИНОМ
Abstract.  Experiments on 40 white non-linear immature male rats evaluated  indices of  renal function with sublimate 
nephropathy at loading by 3% sodium chloride solution in volume of 5% of the body weight under conditions of  blockade 
of renal prostaglandins production with indomethacin and had shown inhibition of diuresis, decrease of sign of the syn-
drome of sodium ions loss.
Key words: sublimate nephropathy, sodium chloride, indomethacin, immature rats.
В опытах на 40 белых нелинейных неполовозрелых (1 месячных) крысах самцах оценка показателей функции 
почек при сулемовой нефропатии с нагрузкой 3% раствором  хлорида натрия в объеме 5% от массы тела в 
условиях блокады продукции почечных простагладинов индометацином показала снижение диуреза, уменьшение 
степени синдрома потери ионов натрия с мочей на фоне гипернатриемии. Расстройства клубочково-канальцевого 
баланса характеризовались потерей положительных корреляционных связей относительной реабсорбции воды с 
клубочковой фильтрацией, фильтрационной фракцией и абсолютной реабсорбцией ионов натрия.
Известно, что при нагрузке 3% расствором  хлорида натрия при сулемовой нефропатии  у половонезрелых крысах 
розвивается полиурическая форма острой почечной недостаточности, что вызывает максимальную мобилизацию 
компенсационных возможностей   простагландина Е2  как  вазодилятатора приносной артериолы почек. Блокада 
почечных простагландиов індометацином за даных условиях призводит к спазму сосудов  почек и развитию 
олигурии. 
Установленные  изменения  клубочково-канальцевого баланса у половонезрелых крысах с сулемовой  нефропатиєй 
при нагрузке 3% раствором  хлорид натрия  на фоне введения индометацина  ведёт к блокаде продукции  почечных 
простагладинов. Сравнительная оценка клубочково-канальцевого баланса в половозрелых и неполовозрелых 
крыс с сулемового нефропатией при нагрузке 3% раствором хлорида натрия в объеме 5% от массы тела в условиях 
блокады продукции почечных простагладинив индометацином обнаружила более существенные расстройства в 
половозрелых крыс с сохранением положительной корреляционной  связи клубочковой фильтрации с абсолютной 
реабсорбцией ионов. Увеличенные показатели относительной реабсорбции воды у неполовозрелых крыс в 
отношении половозрелых животных обусловлен недостаточным уровнем зрелости натрийуретических механизмов 
у животных младшей возрастной группы.
 Ключевые слова: сулемовая нефропатия, нагрузка 3% раствором хлорида натрия, индометацин, неполовозрелые 
крысы, клубочково-канальцевый баланс,
простагландины, гипернатриемия.  
